tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
3 ‘Strong Buy’ Stocks to Buy Today,12/22/2025, According to Top Analysts
PremiumMarket News3 ‘Strong Buy’ Stocks to Buy Today,12/22/2025, According to Top Analysts
27d ago
Wells starts Arcellx with Overweight on multiple myeloma potential
Premium
The Fly
Wells starts Arcellx with Overweight on multiple myeloma potential
27d ago
Arcellx initiated with an Overweight at Wells Fargo
Premium
The Fly
Arcellx initiated with an Overweight at Wells Fargo
27d ago
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
PremiumRatingsArcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
1M ago
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
Premium
Ratings
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
1M ago
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
Premium
Ratings
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
1M ago
Kelonia data too early to read to Gilead, Arcellx’s anito-cel, says BMO Capital
PremiumThe FlyKelonia data too early to read to Gilead, Arcellx’s anito-cel, says BMO Capital
2M ago
Citi says Arcellx weakness on ‘highly preliminary’ Kelonia data an overreaction
Premium
The Fly
Citi says Arcellx weakness on ‘highly preliminary’ Kelonia data an overreaction
2M ago
Arcellx weakness on competitive worries ‘overdone,’ says Guggenheim
Premium
The Fly
Arcellx weakness on competitive worries ‘overdone,’ says Guggenheim
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100